AE Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.15M | Sell |
128,134
-44,852
| -26% | -$752K | 0.02% | 521 |
|
2025
Q1 | $2.66M | Sell |
172,986
-3,888
| -2% | -$59.8K | 0.02% | 461 |
|
2024
Q4 | $3.9M | Sell |
176,874
-18,473
| -9% | -$407K | 0.03% | 389 |
|
2024
Q3 | $3.52M | Sell |
195,347
-3,461
| -2% | -$62.4K | 0.03% | 408 |
|
2024
Q2 | $3.23M | Buy |
198,808
+44,718
| +29% | +$727K | 0.03% | 422 |
|
2024
Q1 | $2.17M | Sell |
154,090
-68,401
| -31% | -$965K | 0.02% | 474 |
|
2023
Q4 | $2.65M | Buy |
+222,491
| New | +$2.65M | 0.01% | 809 |
|